SuperworthCibus CBUS
- Market cap
- $107.8M
- PE
- n/m
- a loss over the last year
- Forward PE
- n/m
- not a meaningful number
- Price to sales
- 24.8×
- EV/EBIT
- n/m
- a loss over the last year
- Revenue, 12 months
- $4.3M
- −10% on a year ago
- Net margin
- n/m
- outside −100% to 100%
- Free cash flow yield
- −43.0%
Cibus trades at 24.8× sales. Its trailing earnings are negative, so it has no PE. Revenue was $4.3M over the last twelve months, down 10% on a year earlier.
Charts
Financials
| Income statement | Q3 FY23 | Q4 FY23 | Q1 FY24 | Q2 FY24 | Q3 FY24 | Q4 FY24 | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $475K+1031% | $1.1M+2526% | $545K+1198% | $838K+325% | $1.7M+251% | $1.2M+10% | $1M+90% | $933K+11% | $615K−63% | $1.1M−13% | $1.7M+63% | $994K+7% | |
| Cost of revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Gross profit | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| R&D | $17.5M+481% | $14.2M+506% | $12M+444% | $13M+54% | $13M−26% | $12.4M−13% | $11.8M−2% | $12.2M−6% | $10.8M−17% | $9.4M−25% | $8.7M−26% | $8.5M−30% |
| SG&A | $8.8M+171% | $6.8M+573% | $7M+204% | $9.3M−16% | $7.7M−12% | $6.8M+0% | $9.9M+41% | $6.7M−29% | $5.3M−31% | $5.1M−25% | $5.1M−48% | $5.4M−19% |
| −$25.8M+316% | −$269.3M+8029% | −$18.5M+314% | −$21.5M+11% | −$200.4M+677% | −$18M−93% | −$41.6M+125% | −$17.9M−17% | −$15.4M−92% | −$22.6M+25% | −$12.1M−71% | −$12.9M−28% | |
| Interest expense | $8.1M | $8.1M | $8.3M | $8.7M+234% | $8.9M+9% | $8.2M+1% | $8.4M+1% | $8.7M−1% | $9M+2% | $9.4M+14% | $9.1M+9% | $9.5M+9% |
| Pre-tax income | −$34.5M+480% | −$277.2M+9671% | −$27M+400% | −$28.5M+39% | −$201.4M+483% | −$25.8M−91% | −$49.4M+83% | −$26.5M−7% | −$24.3M−88% | −$31.9M+24% | −$21.2M−57% | −$22.1M−17% |
| $0 | −$4K | $14K | −$4K | $13K | $6K | $2K−86% | $27K | −$6K | $6K+0% | $7K+250% | $6K−78% | |
| Net income | −$26.4M+344% | −$217.1M+7553% | −$23.4M+335% | −$24.9M+33% | −$180M+581% | −$23.1M−89% | −$46.9M+100% | −$25.4M+2% | −$23.5M−87% | −$31.3M+35% | −$21.2M−55% | −$22.1M−13% |
| −$1.59−75% | −$12.59+330% | −$1.12−80% | −$1.14−63% | −$7.63+380% | −$0.87−93% | −$1.34+20% | −$0.61−47% | −$0.44−94% | −$0.59−32% | −$0.33−75% | −$0.29−53% | |
| 16.6M+1679% | 17.2M+1680% | 20.9M+2011% | 21.9M+256% | 23.6M+42% | 26.5M+54% | 35.1M+68% | 41.6M+91% | 52.9M+124% | 53.2M+100% | 65.2M+86% | 76.8M+84% |
Revenue: Q1 FY16 and Q1 FY17: 6 months less the 3 months printed beside them.
Cost of revenue: Q1 FY16: 6 months less the 3 months printed beside them.
Gross profit: Q1 FY16: 6 months less the 3 months printed beside them. 12 periods, Q2 FY16 to Q3 FY19: not printed by the filing, worked out from its own lines.
R&D: Q1 FY16 and Q1 FY17: 6 months less the 3 months printed beside them.
SG&A: Q1 FY16 and Q1 FY17: 6 months less the 3 months printed beside them.
Operating income: Q1 FY16 and Q1 FY17: 6 months less the 3 months printed beside them.
Pre-tax income: Q1 FY16 and Q1 FY17: 6 months less the 3 months printed beside them.
Income tax: Q1 FY16 and Q1 FY17: 6 months less the 3 months printed beside them.
Net income: Q1 FY16 and Q1 FY17: 6 months less the 3 months printed beside them.
EPS, diluted: 12 periods, Q1 FY16 to Q4 FY25: quarter's net income to common over its shares, to the cent.
Diluted shares: Q1 FY16 and Q1 FY17: share-days: the 6-month average less the second quarter's. 10 periods, Q4 FY16 to Q4 FY25: a loss quarter: its basic count, share-days: the 12-month average less the 9-month, weighted by days.
From each company's 10-Q and 10-K filings, the newest version of each figure. Quarters are as filed (a fourth quarter is the year less its first nine months), fiscal years as the 10-K prints them, restated where a later 10-K restated them, and balance sheet lines as of the period's end. A quarter whose 10-Q isn't filed yet is from the company's results release. Growth is on the same period a year earlier. A dash is a period with no figure for the line: the filing doesn't print it, or it hasn't been read yet.
Peers
Companies in Basic Materials nearest Cibus' size, closest first.
| Company | Market cap | PE | Its 10y median PE | Fwd PE | P/S | Revenue growth | Net margin |
|---|---|---|---|---|---|---|---|
| CBUSCibus | $107.8M | n/m | n/a | 24.8× | −10% | n/m | |
| SMIDSmith Midland | $112.9M | 14.7× | 18.2× | 1.3× | −2% | 8.6% | |
| FTLFFitlife Brands | $78.4M | 13.5× | 15.3× | 0.8× | +61% | 6.2% | |
| BWENBroadwind | $68.6M | n/m | 12.9× | 0.5× | +17% | 3.9% | |
| NAGENiagen Bioscience | $192.3M | 13.5× | 27.0× | 1.5× | +11% | 12.4% | |
| SNDSmart Sand | $201.8M | 18.3× | 12.5× | 0.5× | +27% | 2.7% | |
| ALTOAlto Ingredients | $280M | 5.4× | 13.8× | 0.3× | +1% | 5.5% | |
| FRDFriedman Industries | $301.7M | 10.9× | 9.3× | 0.4× | +62% | 3.6% | |
| BTMDbiote | $38.4M | 10.7× | 12.3× | 0.2× | −8% | 3.2% | |
| IDRIdaho Strategic Resources | $303.5M | 13.5× | 25.5× | 6.0× | +67% | 44.0% | |
| VFFVillage Farms International | $314.9M | 14.3× | 18.3× | 1.4× | −3% | 9.8% | |
| Peer median | $197M | 13.5× | 14.5× | 0.6× | +14% | 5.8% |
More on Cibus
Each number over time
Its groups
About
- Industry
- Agricultural Inputs
- Sector
- Basic Materials
Valuation data, not investment advice. Prices as of .